On Thursday, Moderna Inc (NASDAQ:MRNA) stock is trading higher after the company reported better-than-expected third-quarter ...

Moderna’s (NASDAQ:MRNA) Q3 results confirmed on Thursday that the U.S. vaccine market for respiratory syncytial virus (RSV), ...

Shares of Moderna (NASDAQ:MRNA) traded ~7% higher in the premarket on Thursday after the company swung back to profits on ...

Moderna, Inc. (NASDAQ:MRNA) will release earnings results for its third quarter, before the opening bell on Thursday, Nov. 7.

We recently published a list of the 10 Worst Performing Stocks in S&P 500 in 2024. In this article, we are going to take a ...

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we ...

Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03Achieves year-to-date product sales of $2.2 ...

Drug maker Moderna, Inc. (MRNA) reported Thursday that its third-quarter net income was $13 million, compared to a net loss of $3.63 ...

Shares of Moderna Inc. MRNA slid 2.95% to $50.28 Thursday, on what proved to be an all-around mixed trading session for the ...

In the latest market close, Moderna (MRNA) reached $54.36, with a -0.66% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 1.86%. Meanwhile, the ...

Detailed price information for Moderna Inc (MRNA-Q) from The Globe and Mail including charting and trades.

Current Moderna shareholders who have held Moderna shares since on or before January 18, 2023, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a ...